Added value

Utrecht University (UU) has an excellent research infrastructure in the area of human and animal measurement models, with strong expertise in pharmaceutical sciences, regenerative medicine, and Organ-on-Chip technology. The UU shares a multidisciplinary infrastructure and key technology platforms (e.g., organoids, biofabrication, EV, IPSC, gene-editing) and develops advanced and patient-specific disease models to translate relevant drug targets. The models are translated into novel regenerative therapies based on e.g., living cell-, organoid-, biomaterial- driven and biofabrication- technologies. Fundamental stem cell research integrated with emerging technologies are further used in applied research to bridge interventions to veterinary and human clinical care contributing to the TPI initiative.

 

News

Network

UU has a large network of stakeholders including the world-leading Hubrecht Institute, the University Medical Center Utrecht and the Princess Maxima Center.

Notable strengths of Utrecht research include advanced brain organoids and brain-on-chip models as well as 3D-engineered human cardiomyocytes, articulating joint-on-chip models, and liver-, bone-, cartilage, kidney- and bile duct-on-chip technology. Organized within interdisciplinary research hubs such as the Utrecht Platform for Organoid Technology (UPORT) and the Utrecht Advanced In vitro Models (UAIM) hubs, Utrecht adds further value to the national research landscape.

Added value

Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source. Lorem Ipsum comes from sections 1.10.32 and 1.10.33 of “de Finibus Bonorum et Malorum” (The Extremes of Good and Evil) by Cicero, written in 45 BC.

Contact

Bart Spee

Tina Vermonden

Website
www.uu.nl

Email:

Publications

 

More publications

Relevant grants

 

More grants